86 related articles for article (PubMed ID: 31928997)
1. STAT3 activates the anti-apoptotic form of caspase 9 in oncovirus-infected B lymphocytes.
Koganti S; Burgula S; Bhaduri-McIntosh S
Virology; 2020 Jan; 540():160-164. PubMed ID: 31928997
[TBL] [Abstract][Full Text] [Related]
2. STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation.
Koganti S; Hui-Yuen J; McAllister S; Gardner B; Grasser F; Palendira U; Tangye SG; Freeman AF; Bhaduri-McIntosh S
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4946-51. PubMed ID: 24639502
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
Chen X; Kamranvar SA; Masucci MG
Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
[TBL] [Abstract][Full Text] [Related]
4. Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes.
Koganti S; Clark C; Zhi J; Li X; Chen EI; Chakrabortty S; Hill ER; Bhaduri-McIntosh S
J Virol; 2015 May; 89(9):5002-11. PubMed ID: 25717101
[TBL] [Abstract][Full Text] [Related]
5. STAT3 imparts BRCAness by impairing homologous recombination repair in Epstein-Barr virus-transformed B lymphocytes.
McIntosh MT; Koganti S; Boatwright JL; Li X; Spadaro SV; Brantly AC; Ayers JB; Perez RD; Burton EM; Burgula S; MacCarthy T; Bhaduri-McIntosh S
PLoS Pathog; 2020 Oct; 16(10):e1008849. PubMed ID: 33002095
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferation.
Koganti S; de la Paz A; Freeman AF; Bhaduri-McIntosh S
J Virol; 2014 Jan; 88(1):516-24. PubMed ID: 24173212
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells.
Colombrino E; Rossi E; Ballon G; Terrin L; Indraccolo S; Chieco-Bianchi L; De Rossi A
Exp Cell Res; 2004 May; 295(2):539-48. PubMed ID: 15093750
[TBL] [Abstract][Full Text] [Related]
9. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
J Virol; 2019 May; 93(9):. PubMed ID: 30787154
[TBL] [Abstract][Full Text] [Related]
10. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.
Cahir-McFarland ED; Davidson DM; Schauer SL; Duong J; Kieff E
Proc Natl Acad Sci U S A; 2000 May; 97(11):6055-60. PubMed ID: 10811897
[TBL] [Abstract][Full Text] [Related]
11. CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathway.
Park GB; Kim YS; Lee HK; Cho DH; Kim D; Hur DY
Int J Oncol; 2013 Nov; 43(5):1531-40. PubMed ID: 24008628
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
[TBL] [Abstract][Full Text] [Related]
13. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
Kim YS; Park GB; Choi YM; Kwon OS; Song HK; Kang JS; Kim YI; Lee WJ; Hur DY
Hum Immunol; 2006 Oct; 67(10):795-807. PubMed ID: 17055356
[TBL] [Abstract][Full Text] [Related]
14. Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells.
Mordasini V; Ueda S; Aslandogmus R; Berger C; Gysin C; Hühn D; Sartori AA; Bernasconi M; Nadal D
Oncotarget; 2017 Jan; 8(4):6461-6474. PubMed ID: 28031537
[TBL] [Abstract][Full Text] [Related]
15. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.
Lui VW; Wong EY; Ho Y; Hong B; Wong SC; Tao Q; Choi GC; Au TC; Ho K; Yau DM; Ma BB; Hui EP; Chan AS; Tsang CM; Tsao SW; Grandis JR; Chan AT
Int J Cancer; 2009 Oct; 125(8):1884-93. PubMed ID: 19588483
[TBL] [Abstract][Full Text] [Related]
16. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
Nagy N
Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
Aguirre AJ; Robertson ES
J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
[TBL] [Abstract][Full Text] [Related]
18. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
19. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.
Katsumura KR; Maruo S; Takada K
J Med Virol; 2012 Mar; 84(3):504-10. PubMed ID: 22246839
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
